Considerations in the Care of Athletes With Type 1 Diabetes Mellitus.

Autor:	Pujalte G; Division of Sports Medicine, Mayo Clinic, Jacksonville, USA., Alhumaidi HM; Division of Endocrinology, Mayo Clinic, Jacksonville, USA., Ligaray KPL; Endocrinology, University of Wisconsin, Madison, USA., Vomer RP 2nd; Family Medicine, Eastern Virginia Medical School, Norfolk, USA., Israni K; Department of Family Medicine, Mayo Clinic, Jacksonville, USA., Abadin AA; Department of Family Medicine, Mayo Clinic, Jacksonville, USA., Meek SE; Division of Endocrinology, Mayo Clinic, Jacksonville, USA.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2022 Feb 21; Vol. 14 (2), pp. e22447. Date of Electronic Publication: 2022 Feb 21 (Print Publication: 2022).
DOI:	10.7759/cureus.22447
Abstrakt:	Type 1 diabetes mellitus is an autoimmune disease caused by affected individuals' autoimmune response to their own pancreatic beta-cell. It affects millions of people worldwide. Exercise has numerous health and social benefits for patients with type 1 diabetes mellitus; however, careful management of blood glucose is crucial to minimize the risk of hypoglycemia and hyperglycemia. Anaerobic and aerobic exercises cause different glycemic responses during and after exercise, each of which will affect athletes' ability to reach their target blood glucose ranges. The optimization of the patient's macronutrient consumption, especially carbohydrates, the dosage of basal and short-acting insulin, and the frequent monitoring of blood glucose, will enable athletes to perform at peak levels while reducing their risk of dysglycemia. Despite best efforts, hypoglycemia can occur. Recognition of symptoms and rapid treatment with either fast-acting carbohydrates or glucagon is important. Continuous glucose monitoring devices have become more widely used in preventing hypoglycemia. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2022, Pujalte et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu